tag type-2-diabetes 
Pharmaceutical Technology
JANUARY 17, 2023
Bimagrumab is an activin receptor type 2B (ACVR2B or EC 2.7.11.30) antagonist that offers a unique mechanism of action within the obesity market. Despite its high price tag, bimagrumab’s unique features set it apart from currently marketed therapies. Mounjaro is anticipated to launch in the US later this year or by early 2024.
XTalks
NOVEMBER 3, 2022
Eli Lilly is finding itself in an enviable position with its newly launched diabetes injection Mounjaro (tirzepatide) and blockbuster diabetes med Trulicity due to temporary shortages of competitor Novo Nordisk’s diabetes drug Ozempic (semaglutide). In the third quarter of 2022, Mounjaro scored $187.3
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
MARCH 6, 2024
Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. Food insecurity is associated with diabetes. There was not a statistically significant difference between the 2 groups at 12 months.
Rethinking Clinical Trials
JULY 19, 2023
The objective of COORDINATE-Diabetes trial was to improve the implementation and adoption of these therapies by testing the impact of a clinic-level, multifaceted intervention on the prescription of 3 key groups of evidence-based therapies. in which participants had type 2 diabetes mellitus and ASCVD.
World of DTC Marketing
NOVEMBER 3, 2020
An #NHLBI-funded study put a price tag on American’s bad eating habits: $50 billion a year in health care costs, attributable to cardiometabolic diseases such as heart disease, stroke and type 2 diabetes. In times of stress too many people turn to bad foods as an outlet.
World of DTC Marketing
SEPTEMBER 9, 2021
A study put a price tag on American’s bad eating habits: $50 billion a year in health care costs, attributable to cardiometabolic diseases such as heart disease, stroke, and type 2 diabetes. Then there is the cost of unhealthy Americans.
Rethinking Clinical Trials
SEPTEMBER 22, 2022
Denmark also has registries tracking socioeconomic data such as income and level of education and other types of data that can be linked together for study. With the success of DANFLU-1, the team is launching the fully powered DANFLU-2 trial, which will be conducted the next two years, randomizing 208,000 patients over two flu seasons.
Expert insights. Personalized for you.
130 
Let's personalize your content